Search

Your search keyword '"Karttunen TJ"' showing total 175 results

Search Constraints

Start Over You searched for: Author "Karttunen TJ" Remove constraint Author: "Karttunen TJ"
175 results on '"Karttunen TJ"'

Search Results

3. Intestinal cytokine mRNA expression in delayed-type cow's milk allergy

5. Effect of heat denaturation on beta-lactoglobulin-induced gastrointestinal sensitization in rats : denatured betaLG induces a more intensive local immunologic response than native betaLG

10. Budding invasive margin and prognosis in colorectal cancer - no direct association with beta-catenin expression.

11. Histological synovitis score in juvenile idiopathic arthritis and other pediatric synovial inflammatory conditions.

12. Dynamics of adipose tissue macrophage populations after gastric bypass surgery.

13. Putative anoikis resistant subpopulations are enriched in lymph node metastases and indicate adverse prognosis in colorectal carcinoma.

14. A Straightforward Method for Adipocyte Size and Count Analysis Using Open-source Software QuPath.

15. TLR2 and TLR4 in colorectal cancer: relationship to tumor necrosis and markers of systemic inflammation.

16. Predictive value of p53, Ki67 and TLR5 in neoplastic progression of Barrett's esophagus: a matched case-control study.

17. Risk of progression in Barrett's esophagus based on diagnoses of general and gastrointestinal pathologists. A retrospective case-control study from Northern and Central Finland.

18. Monocarboxylate Transporters 1 and 4 and Prognosis in Small Bowel Neuroendocrine Tumors.

19. Carbonic Anhydrases II, IX, and XII in Reflux Esophagitis.

20. Serological Biomarker Panel in Diagnosis of Atrophic Gastritis and Helicobacter pylori Infection in Gastroscopy Referral Patients: Clinical Validation of the New-Generation GastroPanel ® Test.

21. Carbonic Anhydrases II and IX in Non-ampullary Duodenal Adenomas and Adenocarcinoma.

22. Pathophysiology of reflux oesophagitis: role of Toll-like receptors 2 and 4 and Farnesoid X receptor.

23. Differential synovial tissue expression of TLRs in seropositive and seronegative rheumatoid arthritis: A preliminary report.

24. Immune Cell Infiltrate and Prognosis in Gastric Cancer.

25. Cohort profile: gastric cancer in the population-based, Finnish National Esophago-Gastric Cancer Cohort (FINEGO) Study.

26. Cohort profile: a nationwide population-based retrospective assessment of oesophageal cancer in the Finnish National Esophago-Gastric Cancer Cohort (FINEGO).

27. Systemic inflammation is associated with circulating cell death released keratin 18 fragments in colorectal cancer.

28. Putative anoikis-resistant subpopulations in colorectal carcinoma: a marker of adverse prognosis.

29. Histological assessment of stromal maturity as a prognostic factor in surgically treated gastric adenocarcinoma.

30. KRAS and BRAF mutations induce anoikis resistance and characteristic 3D phenotypes in Caco‑2 cells.

31. Serum TLR2 and TLR4 levels in colorectal cancer and their association with systemic inflammatory markers, tumor characteristics, and disease outcome.

32. Platelet count, aspirin use, and characteristics of host inflammatory responses in colorectal cancer.

33. Tumor Budding and Prognosis in Gastric Adenocarcinoma.

34. Finnish National Esophago-Gastric Cancer Cohort (FINEGO) for studying outcomes after oesophageal and gastric cancer surgery: a protocol for a retrospective, population-based, nationwide cohort study in Finland.

35. Alterations in serum amino-acid profile in the progression of colorectal cancer: associations with systemic inflammation, tumour stage and patient survival.

36. Tenascin C, Fibronectin, and Tumor-Stroma Ratio in Pancreatic Ductal Adenocarcinoma.

37. Toll-like receptors 2, 4 and 9 and hypoxia markers HIF-1alpha and CAIX in pancreatic intraepithelial neoplasia.

38. Carbonic anhydrases II, IX, and XII in Barrett's esophagus and adenocarcinoma.

39. Tumour-stroma ratio and prognosis in gastric adenocarcinoma.

40. Weak HIF-1alpha expression indicates poor prognosis in resectable pancreatic ductal adenocarcinoma.

41. High-serum MMP-8 levels are associated with decreased survival and systemic inflammation in colorectal cancer.

42. Micropapillary Structures in Colorectal Cancer: An Anoikis-resistant Subpopulation.

43. Preoperative anemia in colorectal cancer: relationships with tumor characteristics, systemic inflammation, and survival.

44. Colon epithelial injury in critically ill colectomized patients: aberration of tight junction proteins and Toll-like receptors.

45. Divergent expression of bacterial wall sensing Toll-like receptors 2 and 4 in colorectal cancer.

46. Decreased serum apolipoprotein A1 levels are associated with poor survival and systemic inflammatory response in colorectal cancer.

47. Tenascin-C and fibronectin in normal esophageal mucosa, Barrett's esophagus, dysplasia and adenocarcinoma.

48. Intratumoral lactate metabolism in Barrett's esophagus and adenocarcinoma.

49. High toll-like receptor (TLR) 9 expression is associated with better prognosis in surgically treated pancreatic cancer patients.

50. Localization of nucleic acid-sensing toll-like receptors in human and mouse pancreas.

Catalog

Books, media, physical & digital resources